Genetic susceptibility to mycobacterial disease: Mendelian disorders of the interleukin-12 - Interferon-φ axis;Syndrome de susceptibilite mendélienne aux infections mycobacteriennes: Défauts de l'axe interleukine-12 - Interféron- φ

Revue des Maladies Respiratoires

Volumn 22, Issue 5, 2005, Pages 767-776

  Catherinot, E ^a,b   Fieschi, C ^a   Feinberg, J ^a   Casanova, J L ^a,c   Couderc, L J ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b FOCH HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Immunodeficiency; Interferon gamma; Interleukin 12; Mycobacterium; Salmonella

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BCG VACCINE; CYTOKINE; INTERFERON; INTERLEUKIN 12; STAT1 PROTEIN; ANTIINFECTIVE AGENT; GAMMA INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN RECEPTOR;

ALLELE; ALLOGRAFT; CELLULAR IMMUNITY; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; GENE MUTATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HEMATOPOIESIS; HUMAN; MYCOBACTERIOSIS; PATHOPHYSIOLOGY; PHENOTYPE; RECURRENT DISEASE; REVIEW; RISK FACTOR; TUBERCULOSIS; GENETIC PREDISPOSITION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION;

ANTI-BACTERIAL AGENTS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MYCOBACTERIUM INFECTIONS; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN;

EID: 33644821536     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0761-8425(05)85634-7     Document Type: Short Survey

References (67)

1. Griffith DE, Brown-Elliott BA, and Wallace RJ Jr : Diagnosing non-tuberculous mycobacterial lung disease. A process in evolution. Infect Dis Clin North Am 2002 ; 16 : 235-49.
2. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC : Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999 ; 282 : 677-86.
3. Schluger NW, Rom WN: The host immune response to tuberculosis. Am J Respir Crit Care Med 1998 ; 157 : 679-91.
4. Lotte A, Wasz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E : A bibliography of the complications of BCG vaccination. A comprehensive list of the world literature since the introduction of BCG up to July 1982, supplemented by over 100 personal communications. Adv Tuberc Res 1984 ; 21 : 194-245.
5. Wolinsky E : Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979 ; 119 : 107-59.
6. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE : Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989 ; 321 : 863-8.
7. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, Amara A, Legres L, Dreher D, Nicod LP, Gluckman JC, Lagrange PH, Gicquel B, Neyrolles O: DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003 ; 197 : 121-7.
8. Van Crevel R, Ottenhoff TH, Van der Meer JW : Innate immunity to Mycobacterium tuberculosis. Adv Exp Med Biol 2003 ; 531 : 241-7.
9. Bulut Y, Michelsen K S, Hayrapetian L, Naiki Y, Spallek R, Singh M, Arditi M : Mycobacterium tuberculosis heat shock proteins use diverse TLR pathways to activate pro-inflammatory signals. J Biol Chem 2005 ; 280 : 20961-7.
10. Stenger S, Modlin RL : Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. Curr Opin Immunol 2002 ; 14 : 452-7.
11. Fischer K, Scotet E, Niemeyer M, Koebernick H, Zerrahn J, Maillet S, Hurwitz R, Kursar M, Bonneville M, Kaufmann SH, Schaible UE: Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A 2004 ; 101 : 10685-90.
12. Flynn JL, Ernst JD: Immune responses in tuberculosis. Curr Opin Immunol 2000 ; 12 : 432-6.
13. Watford WT, Moriguchi M, Morinobu A, O'Shea JJ : The biology of IL-12 : coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 2003 ; 14 : 361-8.
14. Larousserie F, Pflanz S, Coulomb-L'Hermine A, Brousse N, Kastelein R, Devergne O : Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 2004 ; 202 : 164-71.
15. Fieschi C, Dupuis S, Picard C, Casanova JL : Human Interleukin-12- Interferon-gamma axis in protective immunity to mycobacteria, In: MK a T Calandra, Editor Cytokines and Chemokines in Infectious Diseases Handbook. Humana Press Inc, Totowa 2003, 151-61.
16. Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol 1997 ; 15 : 749-95.
17. Oppmann B, Lesley R, Blom B, Timans J C, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, and Kastelein RA: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000 ; 13 : 715-25.
18. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, To W, Wagner J, O'Farrell AM, McClanahan T, Zurawski S, Hannum C, Gorman D, Rennick DM, Kastelein RA, De Waal Malefyt R, Moore KW: A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002 ; 168 : 5699-708.
19. Horsburgh CR Jr. : Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991 ; 324 : 1332-8.
20. Falkinham JO : Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996 ; 9 : 177-215.
21. Horsburgh CR, Mason UG, Farhi DC, Iseman MD: Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature. Medicine 1985 ; 64 : 36-48.
22. Reichenbach J, Rosenzweig, S, Döffinger R, Dupuis S, Holland SM, Casanova, JL : Mycobacterial diseases in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 2001 ; 1 : 503-11.
23. Stephan JL, Vlekova V, Le Deist F, Blanche S, Donadieu J, De Saint-Basile G, Durandy A, Griscelli C, Fischer A : Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr 1993 ; 123 : 564-72.
24. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders E A, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrabamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch M C, and Notarangelo LD : Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997 ; 131 : 47-54.
25. Ku CL, Yang K, Bustamante J, Puel A, Von Bernuth H, Santos OF, Lawrence T, Chang HH, Al-Mousa H, Picard C, Casanova JL : Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol Rev 2005 ; 203 : 10-20.
26. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A : Immunological conditions of children with BCG disseminated infection. Lancet 1995 ; 346 : 581.
27. Levin M, Newport MJ, D'Souza S, Kalabalikis P, Brown IN, Lenicker HM, Agius PV, Davies EG, Thrasher A, Klein N, Blackwell J: Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995 ; 345 : 79-83.
28. McKusick VA : Mendelian inheritance in man. Catalogs of human genes and genetic disorders. 12th ed. Johns Hopkins University Press, Baltimore, USA, 1998.
29. Casanova JL, Abel L : Genetic dissection of immunity to mycobacteria: The human model. Annu Rev Immunol 2002 ; 20 : 581-620.
30. Doffinger R, Dupuis S, Picard C, Fieschi C, Feinberg J, Barcenas-Morales G, Casanova JL : Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. Mol Immunol 2002 ; 38 : 903-9.
31. Emile JF, Patey N, Altare F, Lamhamedi S, Jouanguy E, Boman F, Quillard J, Lecomte-Houcke M, Verola O, Mousnier JF, Dijoud F, Blanche S, Fischer A, Brousse N, Casanova JL : Correlation of granuloma structure with clinical outcome defines two types of idiopathic disseminated BCG infection. J Pathol 1997 ; 181 : 25-30.
32. Casanova JL, Blanche S, Emile JF, Jouanguy E, Lamhamedi S, Altare F, Stephan JL, Bernaudin F, Bordigoni P, Turck D, Lachaux A, Albertini M, Bourrillon A, Dommergues JP, Pocidalo MA, Le Deist F, Gaillard JL, Griscelli C, Fischer A : Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study. Pediatrics 1996 ; 98 : 774-8.
33. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, Dorman SE, Fondanèche MC, Dupuis S, Döffinger R, Altare F, Emile JE, Girdelstone J, Ducoulombier H, Edgar D, Clarke J, Oxelius V A, Brai M, Novelli V, Heyne K, Fischer A, Holland S H, Kumararatne DS, Schreiber RD, Casanova JL : A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nature Genet 1999 ; 21 : 370-78.
34. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M : A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996 ; 335 : 1941-9.
35. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, Newport M, Levin M, Blanche S, Seboun E, Fischer A, and Casanova JL : Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996 ; 335 : 1956-61.
36. Dorman SE, Picard C, Lammas D, Heyne K, Van Dissel JT, Baretto R, Rosenzweig SD, Newport M, Levin M, Roesler J, Kumararatne D, Casanova JL, Holland SM : Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004 ; 364 : 2113-21.
37. Rosenzweig S D, Dorman S E, Uzel G, Shaw S, Scurlock A, Brown M R, Buckley RH, Holland SM : A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 2004 ; 173 : 4000-8.
38. Dorman SE, Holland SM : Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998 ; 101 : 2364-9.
39. Dupuis S, Doffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, Abel L, Casanova JL : Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000 ; 178 : 129-37.
40. Feinberg J, Fieschi C, Doffinger R, Feinberg M, Leclerc T, Boisson-Dupuis S, Picard C, Bustamante J, Chapgier A, Filipe-Santos O, Ku CL, De Beaucoudrey L, Reichenbach J, Antoni G, Balde R, Alcais A, Casanova JL : Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol 2004 ; 34 : 3276-84.
41. Fieschi C, Dupuis S, Picard C, Smith CI, Holland SM, Casanova JL : High levels of interferon gamma in the plasma of children with complete interferon gamma receptor deficiency. Pediatrics 2001 ; 107 : E48.
42. Sasaki Y, Nomura A, Kusuhara K, Takada H, Ahmed S, Obinata K, Hamada K, Okimoto Y, Hara T: Genetic basis of patients with bacille Calmette-Guerin osteomyelitis in Japan: identification of dominant partial interferon-gamma receptor 1 deficiency as a predominant type. J Infect Dis 2002 ; 185 : 706-9.
43. Arend SM, Janssen R, Gosen JJ, Waanders H, de Boer T, Ottenhoff TH, van Dissel JT: Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor. Neth J Med 2001 ; 59 : 140-51.
44. Han JY, Rosenzweig SD, Church JA, Holland SM, Ross LA : Variable presentation of disseminated nontuberculous mycobacterial infections in a family with an interferon-gamma receptor mutation. Clin Infect Dis 2004 ; 39 : 868-70.
45. Döffinger R, Jouanguy E, Dupuis S, Fondanèche M C, Stéphan JL, Emile JF, Lamhamedi S, Altare F, Pallier A, Barcenas-Morales G, Krause C, Pestka S, Schreiber RD, Novelli F, Casanova JL : Partial interferon gamma receptor signalling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis 2000 ; 181 : 379-84.
46. Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondaneche MC, Tuerlinckx D, Blanche S, Emile JF, Gaillard JL, Schreiber R, Levin M, Fischer A, Hivroz C, Casanova JL : Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerin infection and a sibling with clinical tuberculosis. J Clin Invest 1997 ; 100 : 2658-64.
47. Dupuis S, Dargemont C, Fieschi C, Thomassin N, Rosenzweig S, Harris J, Holland S M, Schreiber RD, Casanova JL : Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001 ; 293 : 300-3.
48. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen I Z, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P, Al Ghonaium A, Tufenkeji H, Frayha H, Al-Gazlan S, Al-Rayes H, Schreiber RD, Gresser I, Casanova JL : Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 2003 ; 33 : 388-91.
49. Fieschi C, Casanova JL : The role of interleukin-12 in human infectious diseases: only a faint signature. Eur J Immunol 2003 ; 33 : 1461-4.
50. Fieschi C, Dupuis S, Catherinot E, Feinberg J, Bustamante J, Breiman A, Altare F, Baretto R, Le Deist F, Kayal S, Koch H, Richter D, Brezina M, Aksu G, Wood P, Al-Jumaah S, Raspall M, Da Silva Duarte AJ, Tuerlinckx D, Virelizier JL, Fischer A, Enright A, Bernhoft J, Cleary A M, Vermylen C, Rodriguez-Gallego C, Davies G, Blutters-Sawatzki R, Siegrist CA, Ehlayel M S, Novelli V, Haas WH, Levy J, Freihorst J, Al-Hajjar S, Nadal D, De Moraes Vasconcelos D, Jeppsson O, Kutukculer N, Frecerova K, Caragol I, Lammas D, Kumararatne DS, Abel L, Casanova JL : Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor betal deficiency: medical and immunological implications. J Exp Med 2003 ; 197 : 527-35.
51. Fieschi C, Bosticardo M, De Beaucoudrey L, Boisson-Dupuis S, Feinberg J, Filipe Santos O, Bustamante J, Levy J, Candotti F, Casanova JL : A novel form of complete IL-12/IL-23 receptor beta1-deficiency with cell surface-expressed non-functional receptors. Blood 2004 ; 104 : 2095-101.
52. Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Döffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL : Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998 ; 280 : 1432-5.
53. Elloumi-Zghal H, Barbouche MR, Chemli J, Bejaoui M, Harbi A, Snoussi N, Abdelhak S, Dellagi K : Clinical and Genetic Heterogeneity of Inherited Autosomal Recessive Susceptibility to Disseminated Mycobacterium bovis Bacille Calmette-Guerin Infection. J Infect Dis 2002 ; 185 : 1468-75.
54. Altare F, Lammas D, Revy P, Jouanguy E, Döffinger R, Lamhamedi S, Drysdale P, Tollner D, Girdlestone J, Darbyshire P, Wadhwa M, Dockrel H, Salmon M, Fischer A, Durandy A, Casanova J L, and Kumararatne D : Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest 1998 ; 102 : 2035-40.
55. Picard C, Fieschi C, Altare F, Al-Jumaah S, Al-Hajjar S, Feinberg J, Dupuis S, Soudais C, Al-Mohsen IZ, Genin E, Lammas D, Kumararatne DS, Leclerc T, Rafii A, Frayha H, Murugasu B, Wall LB, Sinniah R, Loubser M, Okamoto E, Al-Ghonaium A, Tufenkeji H, Abel L, and Casanova JL : Inherited interleukin-12 deficiency: IL12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002 ; 70 : 336-48.
56. φ-mediated immunity. Immunol Allergy Clin North Amer 2000 ; 20 : 65-76.
57. MacLennan C, Fieschi C, Lammas DA, Picard C, Dorman SE, Sanal O, MacLennan JM, Holland SM, Ottenhoff TH, Casanova JL, Kumararatne DS : Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 2004 ; 190 : 1755-7.
58. φreceptor deficiency. J Pediatr 1999 ; 135 : 640-3.
59. Camcioglu Y, Picard C, Lacoste V, Dupuis S, Akcakaya N, Cokura H, Kaner G, Demirkesen C, Plancoulaine S, Emile J F, Gessain A, Casanova JL : HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency. J Pediatr 2004 ; 144 : 519-23.
60. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997 ; 156 : S1-25.
61. Rosenzweig SD, Holland SM: Defects in the interferon-gamma and interleukin-12 pathways. Immunol Rev 2005 ; 203 : 38-47.
62. Holland SM : Immunotherapy of mycobacterial infections. Semin Respir Infect 2001 ; 16 : 47-59.
63. Ulrichs T, Fieschi C, Nevicka E, Hahn H, Brezina M, Kaufmann SH, Casanova JL, Frecerova K : Variable outcome of experimental interferon-gamma therapy of disseminated Bacillus Calmette-Guerin infection in two unrelated interleukin-12Rbeta1-deficient Slovakian children. Eur J Pediatr 2005 ; 164 : 166-72.
64. Holland SM : Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection. Microbes Infect 2000 ; 2 : 1579-90.
65. Hallstrand TS, Ochs HD, Zhu Q, Liles WC: Inhaled IFN-gamma for persistent nontuberculous mycobacterial pulmonary disease due to functional IFN-gamma deficiency. Eur Respir J 2004 ; 24 : 367-70.
66. Roesler J, Horwitz ME, Picard C, Bordigoni P, Davies G, Koscielniak E, Levin M, Veys P, Reuter U, Schulz A, Thiede C, Klingebiel T, Fischer A, Holland SM, Casanova JL, Friedrich W : Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr 2004 ; 145 : 806-12.
67. Catherinot E, Feinberg J, Fieschi C, Valeyre D, Couderc LJ, and Casanova JL : Non-tuberculous mycobacteria pulmonary disease in patients without predisposing conditions: Interleukin-12-Interferon Gamma axis study (abstract). Am J Respir Crit Care Med 2004 ; 169 : A132.